Suspendido

A Randomised Double Blind Controlled Trial of Injection of Local Anaesthetic and Corticosteroid Under Ultrasound Control in the Greater Trochanteric Pain Syndrome.

0 criterios cumplidosConsulta de un vistazo cómo tu perfil cumple con cada criterio de elegibilidad.
Qué se está evaluando

rapidocain and bethametsaone

+ sterile saline

Medicamento
Quiénes están siendo reclutados

Artritis+2

+ Enfermedades de las Articulaciones

+ Enfermedades del sistema musculoesquelético

A partir de 18 años
Ver todos los criterios de elegibilidad
Cómo está diseñado el estudio

Estudio de Tratamiento

Controlado con PlaceboFase 3
Intervencional
Inicio del estudio: noviembre de 2011
Ver detalles del protocolo

Resumen

Patrocinador PrincipalStephane Genevay
Última actualización: 8 de junio de 2017
Extraido de una base de datos validada por el gobierno.Reclamar como socio

Fecha de inicio: 1 de noviembre de 2011

Fecha en la que se inscribió al primer participante.

The greater trochanteric pain syndrome (GTPS) is a frequent soft tissue syndrome which is often not recognised by medical practitioners. Currently, there is no validated definition of this syndrome and it is classically defined as pain and tenderness in the region of the greater trochanter that may radiate down to the postero-lateral aspect of the thigh and may mimic nerve root compression. The prevalence of GTPS amongst adult patients referred to a spine clinic for chronic low back pain (LBP) has been reported to be 20-35%. In addition to pain, GTPS induces functional disability which at times may profoundly interfere with patients' daily activities. The diagnosis of GTPS is suspected in a patient complaining of lateral hip pain. The reproduction of typical pain on palpation of the posterior part of the greater trochanter is the only well recognised clinical sign, although other clinical signs have been described. As is frequently the case with these type of syndromes, the physiopathology of GTPS is probably a mixture of several musculoskeletal problems, among which trochanteric bursitis and gluteus medius (GMe) tendinosis are the most frequently cited. MRI studies have demonstrated GMe tendinosis or tears in patients with GTPS and MRI is used as the gold standard for the diagnosis of GTPS in many studies. Musculoskeletal ultrasound (US) is of increasing interest among rheumatologists. It readily demonstrates soft tissue lesions, fluid collections, allows dynamic examination and the undertaking of ultrasound guided procedures. GMe and gluteus minus (GMi) tendinopathy or tears as well as bursitis can be clearly demonstrated by ultrasound and US may guide steroid injection for the treatment of GMe tendinopathy. However, to date no study has compared the utility of MRI compared to US. There are very few well-performed studies regarding the treatment of GTPS. Although poorly studied, analgesics and non steroidal anti-inflammatory drugs (NSAIDs) are often used as first line therapy. The duration of therapy required with these oral agents is unknown and there are significant potential side-effects from these treatments. The vast majority of patients referred to secondary or tertiary centres have failed these oral therapies. Some authors advocate physiotherapy (massage or stretching) but once again, there is no strong evidence to support this approach. Thus, most patients are treated with an injection of a combination of steroids and local anaesthetic. However, there is no convincing evidence in the literature that this practice is effective. The use of musculoskeletal ultrasound (US) has been shown to improve the accuracy of corticosteroid injections for many joints and extra-articular structures such as bursa and tendon sheaths. Although small observational studies have suggested that local corticosteroid injection may be effective in the short term, no prospective controlled study has been carried out to establish the efficacy of this common intervention.

Patrocinador PrincipalStephane Genevay
Última actualización: 8 de junio de 2017
Extraido de una base de datos validada por el gobierno.Reclamar como socio

Protocolo

Esta sección proporciona detalles del plan del estudio, incluyendo cómo está diseñado y qué se está evaluando.
Detalles del Diseño

Se reclutarán 46 pacientes

Número total de participantes que el ensayo clínico espera reclutar.

Estudio de Tratamiento

Estos estudios prueban nuevas formas de tratar una enfermedad, condición o problema de salud. El objetivo es determinar si un nuevo medicamento, terapia o enfoque funciona mejor o tiene menos efectos secundarios que las opciones existentes.



Elegibilidad

Los investigadores buscan pacientes que cumplan ciertos criterios, conocidos como criterios de elegibilidad: estado general de salud o tratamientos previos.
Condiciones
Criterios

Cualquier sexo

Sexo biológico de los participantes elegibles para inscribirse.

A partir de 18 años

Rango de edades de los participantes que pueden unirse al estudio.

Voluntarios sanos no permitidos

Indica si personas sanas, sin la condición que se estudia, pueden participar.

Condiciones

Patología

ArtritisEnfermedades de las ArticulacionesEnfermedades del sistema musculoesqueléticoBursitisPeriartritis

Criterios

Inclusion Criteria: Patients complaining of lateral hip pain for more than 1 month. NRS lateral hip pain score ≥ 4 in the preceding week. Failure of another "standard" treatment: Physiotherapy: local therapy or a stretching program, or Analgesic treatment (minimum of 5 days of consecutive therapy, including, but not limited to, NSAIDs). Typical lateral hip pain reproduced by palpation of the greater trochanter Exclusion Criteria: Age younger than 18 years old Concomitant local surgical intervention for tumours, infection or fracture, based on clinical history and physical examination Previous ipsilateral prosthetic hip surgery Scheduled ipsilateral hip surgery within 3 months Fibromyalgia (diagnosis established by a rheumatologist) Flair of chronic inflammatory joint disease (as defined by a rheumatologist) Skin lesions at the injection site Allergy to one of the studied drugs Anticoagulation with internal normalized ration (INR) >3 Blood coagulation disorder, such as haemophilia. Serious and uncontrolled psychiatric disease (as assessed by the clinician as a contraindication for steroid) Other contraindications to steroid use, such as: uncontrolled diabetes (non-fasting blood glucose > 10 mmol/L) unstable hypertension (systolic pressure > 160mmHg or diastolic pressure > 100mmHg), or open or closed angle glaucoma. Requirement for systemic steroids (including steroid injections) or dose modification of disease modifying anti-rheumatic drugs during the preceding three months. Oral corticosteroids (< 10mg / day of Prednisone or equivalent) will be permitted providing that the dose has been stable for 4 weeks prior to inclusion and that the patient is expected to remain on the baseline dose for the duration of the study. Presence of a pacemaker or other metallic object that constitutes a CI to MRI, or severe claustrophobia Pregnant women (according to a pregnancy test) or nursing (breastfeeding) mothers. Unwillingness or inability to give informed consent. Unavailability for follow-up

Plan de Estudio

Conoce todos los tratamientos administrados en este estudio, su descripción detallada y en qué consisten.
Grupos de Tratamiento
Objetivos del Estudio

2 grupos de intervención están designados en este estudio

50% de probabilidad de ser asignado al grupo placebo

Grupos de Tratamiento

Grupo I

Comparador Activo
Rapidocain and Bethametsaone : Lidocaine (Rapidocain(R)): 4ml of 1% Lidocaine Bethametasone (Diprophos): 1ml ampoule (containing 5mg/ml dipropionate de bétaméthasone and 2mg/ml phosphate disodique de bétaméthasone)

Grupo II

Placebo
Placebo arm with 5ml of sterile saline (NaCl) solution

Objetivos del Estudio

Objetivos Primarios

Objetivos Secundarios

Centros del Estudio

Estos son los hospitales, clínicas o centros de investigación donde se lleva a cabo el estudio. Puedes encontrar la ubicación más cercana a ti y su estado de reclutamiento.

Este estudio tiene una ubicación

University Hospital, Geneva

Geneva, SwitzerlandAbrir University Hospital, Geneva en Google Maps
Suspendido1 Centros de Estudio